Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 30, 2015 15:27 ET | Source: Evotec AG

Evotec’s Partner Roche Provides Initial Update From Phase IIb Trial in Alzheimer’s Disease

HAMBURG, Germany, June 30, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) was updated today by its partner Roche (SIX:RO) (SIX:ROG) (OTCQX:RHHBY) on the initial...
June 09, 2015 11:21 ET | Source: Evotec AG

Resolutions of the Annual General Meeting of Evotec AG

Approval of All Agenda Items With the Required MajorityActions of Management Board and Supervisory Board ApprovedNew Supervisory Board Member Elected: Dr. Elaine SullivanContingent Capital for the...
May 27, 2015 08:22 ET | Source: Evotec AG

Evotec to Present at the Jefferies 2015 Global Healthcare Conference (New York)

HAMBURG, Germany, May 27, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) announced today that its CEO, Dr. Werner Lanthaler will present at the Jefferies 2015 Global...
May 12, 2015 01:52 ET | Source: Evotec AG

Evotec AG Reports Results of First Quarter 2015

VERY STRONG START TO 2015: 22% GROWTH OF GROUP REVENUES, MAINLY DRIVEN BY EVT EXECUTE MAJOR MULTI-COMPONENT STRATEGIC ALLIANCE WITH SANOFI CLOSED FULL-YEAR REVENUE GUIDANCE...
April 29, 2015 01:40 ET | Source: Evotec AG

Facio Partners With Evotec and Initiates FSHD Drug Discovery Programme

HAMBURG, Germany, April 29, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) and Facio Therapies ("Facio") announced today that they have entered into an agreement aimed...
March 24, 2015 02:45 ET | Source: Evotec AG

Evotec FY 2014: Strong Performance in EVT Execute and Acceleration of EVT Innovate

HAMBURG, Germany, March 24, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Prime Standard Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) today announced its financial results for the fiscal year...
March 19, 2015 20:11 ET | Source: Evotec AG

Evotec and Sanofi Sign Definitive Agreement for Major Multi-Component Strategic Alliance

Total deal value of € 250 m, including more than € 40 m upfront cash payment Long-term discovery service collaboration with Sanofi Major pipeline-building...
March 17, 2015 06:38 ET | Source: Evotec AG

Evotec AG: Fiscal Year 2014 Results Presentation on 24 March 2015

HAMBURG, Germany, March 17, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for 2014 on Tuesday, 24 March 2015. The...
March 13, 2015 02:46 ET | Source: Evotec AG

Second Genome and Evotec to Collaborate in Microbiome Discovery and Development

HAMBURG, Germany, March 13, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) and Second Genome, Inc. today announced a collaboration in small molecule-based discovery...
January 19, 2015 01:38 ET | Source: Evotec AG

Evotec and C4XD Enter Collaboration to Identify Pre-Clinical Development Candidates for Stress-Related Addictive Disorder Programme

Collaboration leverages the breadth & experience of Evotec's drug discovery infrastructure across chemistry & biology Efforts will combine the use of C4XD's proprietary NMR technology...